Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Context Therapeutics Inc (CNTX)

58 + Investors. Track Smart Money conviction in CNTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
2Q ▲
Buyers last Q
62%

Smart Money Signals — CNTX

Based on 58 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added CNTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
58 hedge funds hold CNTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +38% more funds vs a year ago

fund count last 6Q
+16 new funds entered over the past year (+38% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 62% buying

34 buying21 selling
Last quarter: 34 funds were net buyers (24 opened a brand new position + 10 added to an existing one). Only 21 were sellers (13 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+15 vs last Q)

new funds entering per quarter
Funds opening a new CNTX position: 4 → 6 → 9 → 24. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 41% entered in last year

■ 22% conviction (2yr+) ■ 36% medium ■ 41% new
Only 13 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +101% but shares only +14% — price-driven

Value
+101%
Shares
+13%
Last quarter: the total dollar value of institutional holdings rose +101%, but actual share count only changed +14%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

4 → 4 → 6 → 9 → 24 new funds/Q
New funds entering each quarter: 4 → 6 → 9 → 24. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊

Mixed cohorts — 32% veterans, 41% new entrants

■ 32% veterans ■ 27% 1-2yr ■ 41% new
Of 59 current holders: 19 (32%) held 2+ years, 16 held 1–2 years, 24 (41%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 11% AUM from top-100

11% from top-100 AUM funds
14 of 57 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.6
out of 10
Moderate Exit Risk
Exit risk score 4.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CNTX

In 2026 Q1, 34 hedge funds were net buyers of CNTX (24 opened a new position, 10 added to an existing one), while 21 reduced or exited (13 trimmed, 8 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 58.

Hedge Fund Ownership: CNTX

How many hedge funds hold CNTX — quarterly history vs. share price
Quarterly hedge fund ownership of CNTX vs. share price

Market Analysis: CNTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CNTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Context Therapeutics Inc (CNTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CNTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
CNTX
nan%
XLV
+2.1%

CNTX outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
CNTX
nan%
XLV
+3.2%

Since the filing became public, CNTX outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
2.0
/ 10
conviction
Hedge Fund Positioning: CNTX
58 + Investors

Track Smart Money conviction in CNTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 58 42 38.1%
13F Shares 74M 65M 13.83%
Total Value $193M $96M 101.44%
New Positions 24 9 +15
Increased Positions 10 8 +2
Closed Positions 8 4 +4
Reduced Positions 13 8 +5
Total Calls 1 0 100%
Total Puts 1 0 100%
PUT/CALL Ratio 1.0 0.0 Neutral

Statistics: CNTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

58 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CNTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 CNTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Blue Owl Capital Holdings LP 3.58% 5,089,015 $13.3M
2 Avidity Partners Management LP 2.67% 4,998,267 $11.8M
3 MPM BioImpact LLC 2.16% 10,679,391 $28.0M
4 Octagon Capital Advisors LP 1.52% 5,250,000 $13.8M
5 Nextech Invest, Ltd. 1.37% 7,419,355 $19.4M
6 Great Point Partners LLC 1.35% 2,238,496 $5.9M
7 Squadron Capital Management LLC 1.06% 1,100,000 $2.9M
8 Soleus Capital Management, L.P. 0.74% 6,963,141 $18.2M
9 Sio Capital Management, LLC 0.34% 917,922 $2.4M
10 Deep Track Capital, LP 0.32% 7,419,355 $19.4M
11 TCG Crossover Management, LLC 0.20% 2,682,696 $7.0M
12 Velan Capital Investment Management LP 0.16% 100,000 $262K
13 Seven Fleet Capital Management LP 0.16% 190,785 $500K
14 Cormorant Asset Management, LP 0.07% 529,550 $1.4M
15 ADAR1 Capital Management, LLC 0.05% 351,094 $920K
16 Clear Harbor Asset Management, LLC 0.02% 92,804 $243K
17 Marshall Wace, LLP 0.01% 2,948,441 $7.7M
18 WINTON GROUP Ltd 0.01% 81,303 $213K
19 Mill Creek Capital Advisors, LLC 0.01% 104,631 $274K
20 Legacy Capital Wealth Partners, LLC 0.01% 10,315 $27K
21 Adage Capital Partners GP, L.L.C. 0.00% 1,000,000 $2.6M
22 Two Sigma Securities, LLC 0.00% 12,573 $33K
23 Woodline Partners LP 0.00% 250,088 $655K
24 Franklin Resources Inc 0.00% 3,803,338 $10.0M
25 Strive Financial Group ,LLC 0.00% 1,700 $4K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Context Therapeutics Inc (CNTX)

What does the Smart Money Trend signal show for CNTX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CNTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CNTX?

More buyers than sellers — 62% buying: Last quarter: 34 funds were net buyers (24 opened a brand new position + 10 added to an existing one). Only 21 were sellers (13 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for CNTX holders?

Smaller funds dominant — 11% AUM from top-100: 14 of 57 holders rank in the top 100 by AUM, but together hold only 11% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held CNTX?

Mostly new holders — 41% entered in last year: Only 13 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Context Therapeutics Inc (CNTX) following the 2026 Q1 hedge fund 13F filings?

As of today, CNTX has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), CNTX has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →